Newborn with Prenatally Detected Unilateral Hydronephrosis and a Prolonged Antibiotic Course

This is high-grade postnatal hydronephrosis by APD criteria (SFU grade 3-4 territory given APD >10 mm plus cortical thinning), and the dilated ureter shifts the differential toward ureterovesical junction obstruction or primary megaureter, with ureteropelvic junction obstruction less likely as the sole lesion. Vesicoureteral reflux must still be excluded because reflux can produce both pelvic and ureteral dilation.

Key reasoning points:

• Timing matters. Day-3 ultrasound in a neonate is physiologically dehydrated; APD can underestimate or overestimate true dilation. A repeat study at 4-6 weeks in a well-hydrated infant is standard before committing to surgery.
• VCUG first. The dilated ureter raises the pretest probability of VUR and also screens for posterior urethral valves (unlikely here given normal bladder and normal voiding, but the study is already ordered).
• Renogram is for function and drainage, not for diagnosis alone. MAG3 with furosemide is most interpretable after ~4-6 weeks of age; performing it in the first weeks risks a misleading t-half. Differential function <40% or a persistently obstructive washout pattern would push toward intervention.
• Do not operate on a single ultrasound. Surgery is indicated for declining differential function, high-grade obstruction with poor drainage, breakthrough febrile UTI, or progressive thinning, not for APD alone.

Continuous antibiotic prophylaxis in high-grade hydronephrosis is intended to prevent febrile UTI and renal scarring during the window before obstruction/reflux is characterized and before the infant is fully immunized and older.

My recommendation: continue prophylaxis through the diagnostic evaluation (VCUG and renogram), then reassess.

• If VUR (especially high-grade) or significant obstruction is confirmed, continue until the lesion is resolved or surgically addressed.
• If both studies are reassuring and the hydronephrosis is stable or improving, prophylaxis can reasonably be discontinued with a plan for surveillance ultrasound and parental education about febrile illness.

What would change my mind toward earlier discontinuation: a completely normal VCUG, a non-obstructive renogram with preserved function, and a stable or improving repeat ultrasound. What would change it toward indefinite continuation: febrile UTI at any point, high-grade VUR, or declining function. I would also confirm the dosing is appropriate for weight and that the family understands prophylaxis is not a substitute for prompt evaluation of fever.

A differential function of 38% is below the conventional 40% threshold but is not by itself an absolute operative indication, especially in a thriving infant with a single measurement. The prolonged t-half in a neonate is also confounded by immature renal function and bladder filling.

Management:

1. Repeat the renogram in 4-8 weeks (or use a standardized protocol with bladder catheter and hydration) to confirm the function and drainage pattern rather than acting on one study.
2. Continue prophylaxis in the interim given high-grade hydronephrosis and borderline function.
3. Serial ultrasound every 3 months in the first year to track APD, cortical thickness, and growth.
4. Surgical trigger: a confirmed decline in differential function (e.g., falling below ~35-40% on repeat, or a drop of >5-10% from baseline), worsening drainage with rising APD and cortical thinning, breakthrough febrile UTI, or hypertension. If any occur, pyeloplasty (or ureteral reimplant/dismembered repair depending on the level of obstruction) is warranted.
5. Counsel the family that many high-grade neonatal hydronephroses improve spontaneously and that the goal is to operate before irreversible loss of function, not to operate on a number.